Alveogene
1 known investors
AlveoGene is a gene therapy company developing inhaled treatments aimed at improving outcomes for patients with rare respiratory diseases. It operates in the biotech sector with a product pipeline focused on inhaled gene therapy.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Alveogene do?
- AlveoGene is a gene therapy company developing inhaled treatments aimed at improving outcomes for patients with rare respiratory diseases. It operates in the biotech sector with a product pipeline focused on inhaled gene therapy.
- Who are Alveogene's investors?
- Alveogene's investors include Oxford Science Enterprises.